Drugs / Wobe-Mugos E
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00014339 | Mar 2000 → ? | plasma cell myeloma | Medsearch | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Wobe-Mugos E | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00014339 ↗ |
| Modality | Protein / enzyme biologic | “Enzyme products such as Wobe-Mugos E may help to reduce the side effects of multiple myeloma therapy.” NCT00014339 ↗ |
| Route | Oral | “oral Wobe-Mugos E” NCT00014339 ↗ |